Literature DB >> 17721331

Small chronic pneumothoraces and pulmonary parenchymal abnormalities after bone marrow transplantation.

Nicola Sverzellati1, Maurizio Zompatori, Venerino Poletti, Duncan M Geddes, David M Hansell.   

Abstract

The features of 4 allogeneic bone marrow transplant patients with an unusual late-onset complication of pulmonary abnormalities with small chronic pneumothoraces are described. Thin-section computed tomography demonstrated upper zone fibrotic changes and diffuse abnormalities suggestive of constrictive obliterative bronchiolitis. An important feature of the pneumothoraces was that they tended to be recurrent and small. We suggest that awareness of this unusual association may be useful in the radiologic evaluation of late-onset pulmonary complications after allogeneic bone marrow transplantation.

Entities:  

Mesh:

Year:  2007        PMID: 17721331     DOI: 10.1097/RTI.0b013e31802bddca

Source DB:  PubMed          Journal:  J Thorac Imaging        ISSN: 0883-5993            Impact factor:   3.000


  3 in total

1.  Pleuroparenchymal fibroelastosis: the prevalence of secondary forms in hematopoietic stem cell and lung transplantation recipients.

Authors:  Francesca Mariani; Beatrice Gatti; Alberto Rocca; Francesca Bonifazi; Alberto Cavazza; Stefano Fanti; Sara Tomassetti; Sara Piciucchi; Venerino Poletti; Maurizio Zompatori
Journal:  Diagn Interv Radiol       Date:  2016 Sep-Oct       Impact factor: 2.630

Review 2.  Pleuroparenchymal Fibroelastosis. A Review of Clinical, Radiological, and Pathological Characteristics.

Authors:  Felix Chua; Sujal R Desai; Andrew G Nicholson; Anand Devaraj; Elisabetta Renzoni; Alexandra Rice; Athol U Wells
Journal:  Ann Am Thorac Soc       Date:  2019-11

3.  Pulmonary radiological findings in patients with acute myeloid leukemia and their relationship to chemotherapy and prognosis: a single-center retrospective study.

Authors:  Mehmet S Buğdacı; Halil Yanardağ; M Cem Ar; Teoman Soysal; Süleyman Coşkun; Sabriye Demirci
Journal:  Turk J Haematol       Date:  2012-09-15       Impact factor: 1.831

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.